High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
José Rodríguez(The University of Texas MD Anderson Cancer Center), Eulogio Conde(Marqués de Valdecilla University Hospital), Jesús F. San Miguel(Clinica Universidad de Navarra), Jorge Sierra(Universitat Autònoma de Barcelona), Enric Carreras(Josep Carreras Leukaemia Research Institute), J Zuazu(Institut Català d'Oncologia), Alberto Fernández de Sevilla(Duran i Reynals Hospital), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Ángel León(Hospital Jerez Puerta del Sur), Marı́a Dolores Caballero(Complejo Hospitalario de Salamanca), Marco Gandarillas, Jesús Marı́n, Antonio Gutiérrez(Hospital Universitario Son Dureta), Reyes Arranz, Armando López‐Guillermo(Barcelona Supercomputing Center)
PubMed
December 1, 2003
Cited by 54
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k